NZ711985A - Anti-infective agents comprising lactadherin and/or protease-generated digestion products thereof - Google Patents

Anti-infective agents comprising lactadherin and/or protease-generated digestion products thereof

Info

Publication number
NZ711985A
NZ711985A NZ711985A NZ71198514A NZ711985A NZ 711985 A NZ711985 A NZ 711985A NZ 711985 A NZ711985 A NZ 711985A NZ 71198514 A NZ71198514 A NZ 71198514A NZ 711985 A NZ711985 A NZ 711985A
Authority
NZ
New Zealand
Prior art keywords
lactadherin
infection
protease
infective agents
digestion products
Prior art date
Application number
NZ711985A
Inventor
Ken Katoh
Toshiya Kobayashi
Hiroshi Urazono
Tomoki Takahashi
Yuki Mizuno
Koichiro Yoshioka
Original Assignee
Megmilk Snow Brand Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Megmilk Snow Brand Co Ltd filed Critical Megmilk Snow Brand Co Ltd
Publication of NZ711985A publication Critical patent/NZ711985A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A23K20/147—Polymeric derivatives, e.g. peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Immunology (AREA)
  • Animal Husbandry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Fodder In General (AREA)

Abstract

The present invention relates to an infection phylactic agent which exhibits a protective effect against influenza virus infection and is useful in the prevention and/or treatment of influenza. This infection protection agent contains, as an active component, lactadherin and/or a decomposition product obtained by treating lactadherin with a proteolytic enzyme. Having mammalian milk as the raw ingredient, this infection protection agent can be easily and economically produced and can be safely ingested on a daily basis.
NZ711985A 2013-03-08 2014-03-07 Anti-infective agents comprising lactadherin and/or protease-generated digestion products thereof NZ711985A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2013046737A JP6346405B2 (en) 2013-03-08 2013-03-08 Infection preventive
PCT/JP2014/055931 WO2014136931A1 (en) 2013-03-08 2014-03-07 Infection protection agent

Publications (1)

Publication Number Publication Date
NZ711985A true NZ711985A (en) 2020-06-26

Family

ID=51491438

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ711985A NZ711985A (en) 2013-03-08 2014-03-07 Anti-infective agents comprising lactadherin and/or protease-generated digestion products thereof

Country Status (8)

Country Link
JP (1) JP6346405B2 (en)
CN (1) CN105025914B (en)
AU (1) AU2014226864B2 (en)
HK (1) HK1210942A1 (en)
MY (1) MY179921A (en)
NZ (1) NZ711985A (en)
TW (1) TWI646969B (en)
WO (1) WO2014136931A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016104642A1 (en) * 2014-12-25 2016-06-30 一般財団法人糧食研究会 Emulsion stabilizer and emulsion stabilization method using same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5130598B2 (en) * 2005-09-02 2013-01-30 静岡県公立大学法人 Method for discriminating specificity of virus receptor sugar chain recognition
JP2008031156A (en) * 2006-07-07 2008-02-14 National Univ Corp Shizuoka Univ Antiviral agent
US8450441B2 (en) * 2007-06-28 2013-05-28 National University Corporation Shizuoka University Synthetic N-linked sialo-glycan-containing polymer and method for producing the same
EP2389952A1 (en) * 2010-05-31 2011-11-30 Rotalactis Srl Lactadherin-derived peptides as antiviral agents
CA2834516A1 (en) * 2011-04-28 2012-11-01 The Feinstein Institute For Medical Research Mfg-e8 and uses thereof

Also Published As

Publication number Publication date
AU2014226864B2 (en) 2018-09-13
HK1210942A1 (en) 2016-05-13
CN105025914A (en) 2015-11-04
WO2014136931A1 (en) 2014-09-12
AU2014226864A1 (en) 2015-09-24
JP2014172862A (en) 2014-09-22
CN105025914B (en) 2020-02-18
TWI646969B (en) 2019-01-11
JP6346405B2 (en) 2018-06-20
TW201446257A (en) 2014-12-16
MY179921A (en) 2020-11-19

Similar Documents

Publication Publication Date Title
PH12017502298B1 (en) Antibacterial compounds
MX2016006221A (en) Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants and young children.
PL3656384T3 (en) Combinations comprising 5-phenoxy-3h-pyrimidin-4-one derivatives and their use for the prophylaxis or treatment of infection by hiv
PH12015500724A1 (en) 1, 2, 4-triazine derivatives for the treatment of viral infections
EA201590703A1 (en) MEK INHIBITORS FOR TREATING VIRAL DISEASES
BR112015029487A8 (en) rebaudioside-e and food products sweetened with rebaudioside-e
MX2015011193A (en) Antiviral compounds.
WO2015058664A8 (en) Use of icaritin in preparing medicament for preventing or treating hematocytopenia
MY196089A (en) Agent or Method for Treatment and/or Prevention of Accelerated Energy Expenditure and/or Diminished Energy Expenditure Functionality
TN2015000255A1 (en) Chitin or derivatives thereof for the prevention and/or treatment of parasitoses
EP2538946A4 (en) Anti-viral formulations
PH12016500465A1 (en) Deoxynojirimycin derivatives and methods of their using
PH12017500706A1 (en) Composition containing extract or fraction of genus justicia plant
MX2012007166A (en) Synergistic antiviral composition and use thereof.
IN2014CN00572A (en)
TN2015000406A1 (en) Antimicrobial compositions and related methods of use
PH12014502680A1 (en) Polysaccharide compositions and methods of use
MX2012008890A (en) Combination composition, comprising as active ingredient l-carnitine or propionyl l-carnitine, for the prevention or treatment of chronic venous insufficiency.
MX2014001329A (en) Use of lactic acid bacteria to reduce pathogens and as a bio-sanitizer.
NZ728284A (en) Treatment and prevention of the common cold using povidone-iodine
MX2015011198A (en) Antiviral compounds.
PH12015501131A1 (en) Fibrinolytic compositions comprising bromelain and nattokinase for the prevention and treatment of phlebothrombotic states
IN2014DN05865A (en)
NZ711985A (en) Anti-infective agents comprising lactadherin and/or protease-generated digestion products thereof
MX2014011218A (en) Use of amphoteric surfactants for the prevention and treatment of pathogenic vaginal biofilms in vaginal infections.

Legal Events

Date Code Title Description
ERR Error or correction

Free format text: THE TITLE HAS BEEN CORRECTED TO TITLE: INFECTION PROTECTION AGENT; FILING DATE: 07 SEP 2015; STATUS: REJECTED; KIND CODE: A1 PUBLICATION DATE: 25 SEP 2015; TITLE: INFECTION PROTECTION AGENT; FILING DATE: 23 DEC 2019; STATUS: REJECTED; KIND CODE: TITLE: ANTI-INFECTIVE AGENTS COMPRISING LACTADHERIN AND/OR PROTEASE-GENERATED DIGESTION PRODUCTS THEREOF; FILING DATE: 30 APR 2020; STATUS: PROPOSED; KIND CODE:

Effective date: 20200511

PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 07 MAR 2022 BY CPA GLOBAL

Effective date: 20210128

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 07 MAR 2023 BY CPA GLOBAL

Effective date: 20220128

LAPS Patent lapsed